To the best of our knowledge, this study on the irAEs and their association with the effectiveness of PD-1/PD-L1 inhibitors in NSCLC is by far the one with the largest number of patients in the real-world NSCLC Chinese population. Here, PDCD1 is linked to non-small cell lung carcinoma.